Profile picture

Professor Stefano Perlini

University of Pavia, Pavia (Italy)
Membership: FESC Member
Follow
Logo ESC

Contributor content

Comparative efficacy and safety of tafamidis versus acoramidis in transthyretin amyloid cardiomyopathy: a matching-adjusted indirect comparison
Presentation
Comparative efficacy and safety of tafamidis versus acoramidis in transthyretin amyloid cardiomyopathy: a matching-adjusted indirect comparison
Read more
Q&A
Presentation
Q&A
Read more
Panel discussion
Presentation
Panel discussion
Read more
From evidence to outcomes: leveraging long-term data in ATTR-CM
Presentation
From evidence to outcomes: leveraging long-term data in ATTR-CM
Read more
Transthyretin (TTR) stabilisation in ATTR cardiomyopathy: myths, measures, and meaning
Presentation
Transthyretin (TTR) stabilisation in ATTR cardiomyopathy: myths, measures, and meaning
Read more
Transthyretin (TTR) stabilisation in ATTR cardiomyopathy: myths, measures, and meaning
Presentation
Transthyretin (TTR) stabilisation in ATTR cardiomyopathy: myths, measures, and meaning
Read more
How can trial and real-world ATTR cardiomyopathy data support clinical practice?
Presentation
How can trial and real-world ATTR cardiomyopathy data support clinical practice?
Read more
Management of ATTR-CM: from clinical trial data to real-world evidence
Presentation
Management of ATTR-CM: from clinical trial data to real-world evidence
Read more
The correct diagnosis in this case, and why
Presentation
The correct diagnosis in this case, and why
Read more
Case presentation, panel discussion, and audience questions
Presentation
Case presentation, panel discussion, and audience questions
Read more

ESC 365 is supported by

novartis Explore sponsored resources